$VCEL
Vericel Corp Stock $vcel

$vcel Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-K Financial Statement

#000162828020002229 Filed on February 25, 2020

Income Statement

Concept	2018 Q4	2018 Q3	2018 Q2
Revenue	$31.34M	$22.48M	$19.01M
YoY Change	34.2%	57.67%	12.14%
Cost Of Revenue	$8.630M	$8.140M	$7.730M
YoY Change	2.86%	13.28%	0.78%
Gross Profit	$22.71M	$14.35M	$11.28M
YoY Change	51.77%	102.8%	21.56%
Gross Profit Margin	72.46%	63.81%	59.36%
Selling, General & Admin	$13.69M	$12.57M	$11.79M
YoY Change	34.48%	53.54%	33.49%
% of Gross Profit	60.29%	87.61%	104.49%
Research & Development	$3.020M	$3.113M	$3.739M
YoY Change	-15.88%	6.65%	25.85%
% of Gross Profit	13.3%	21.7%	33.14%
Depreciation & Amortization	$300.0K	$320.0K	$380.0K
YoY Change	-28.57%	-21.95%	2.7%
% of Gross Profit	1.32%	2.23%	3.37%
Operating Expenses	$16.71M	$15.68M	$15.53M
YoY Change	21.35%	41.22%	31.57%
Operating Profit	$5.995M	-$1.336M	-$4.246M
YoY Change	403.36%	-66.86%	68.43%
Interest Expense	$160.0K	$460.0K	$448.0K
YoY Change	220.0%	45.11%	49.83%
% of Operating Profit	2.67%
Other Income/Expense, Net	-$80.00K	$267.0K	-$405.0K
YoY Change	-20.0%	-119.4%	-404.51%
Pretax Income	$5.240M	-$1.070M	-$4.650M
YoY Change	1706.9%	-80.22%	94.56%
Income Tax
% Of Pretax Income
Net Earnings	$5.242M	-$1.069M	-$4.651M
YoY Change	1726.48%	-80.23%	94.77%
Net Earnings / Revenue	16.73%	-4.75%	-24.46%
Basic Earnings Per Share	$0.12	-$0.02	-$0.12
Diluted Earnings Per Share	$0.11	-$0.02	-$0.12
COMMON SHARES
Basic Shares Outstanding	43.35M shares	42.93M shares	36.68M shares
Diluted Shares Outstanding		42.93M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$82.90M	$97.80M	$95.00M
YoY Change	208.18%	530.97%	578.57%
Cash & Equivalents	$18.29M	$53.29M	$94.97M
Short-Term Investments	$64.60M	$44.50M
Other Short-Term Assets	$2.847M	$2.339M	$1.327M
YoY Change	80.08%	71.23%	18.91%
Inventory	$3.558M	$3.638M	$3.725M
Prepaid Expenses
Receivables	$23.45M	$15.53M	$17.50M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$112.8M	$119.3M	$117.5M
YoY Change	123.31%	228.43%	255.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.906M	$5.207M	$4.673M
YoY Change	45.07%	31.26%	33.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$5.906M	$5.207M	$4.673M
YoY Change	45.07%	31.26%	33.78%
TOTAL ASSETS
Total Short-Term Assets	$112.8M	$119.3M	$117.5M
Total Long-Term Assets	$5.906M	$5.207M	$4.673M
Total Assets	$118.7M	$124.5M	$122.2M
YoY Change	117.47%	209.01%	234.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.108M	$4.580M	$5.011M
YoY Change	28.03%	-23.31%	-20.11%
Accrued Expenses	$6.930M	$5.600M	$5.100M
YoY Change	24.35%	1377.57%	765.87%
Deferred Revenue		$534.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$4.100M	$2.800M
YoY Change	-100.0%	57.69%	33.33%
Total Short-Term Liabilities	$14.79M	$14.99M	$15.22M
YoY Change	13.0%	3.19%	17.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$13.18M	$14.42M
YoY Change	-100.0%	78.15%	79.3%
Other Long-Term Liabilities	$1.666M	$1.800M	$2.000M
YoY Change	-20.67%		18081.82%
Total Long-Term Liabilities	$1.666M	$13.18M	$14.42M
YoY Change	-19.09%	78.15%	79.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.79M	$14.99M	$15.22M
Total Long-Term Liabilities	$1.666M	$13.18M	$14.42M
Total Liabilities	$16.46M	$29.99M	$31.60M
YoY Change	-48.63%	27.39%	40.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$369.0M	-$374.3M	-$373.2M
YoY Change	2.25%	3.62%	4.9%
Common Stock	$471.2M	$468.4M	$463.5M
YoY Change	23.02%	24.02%	25.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$102.2M	$94.48M	$90.60M
YoY Change
Total Liabilities & Shareholders Equity	$118.7M	$124.5M	$122.2M
YoY Change	117.47%	209.01%	234.46%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2018 Q2
OPERATING ACTIVITIES
Net Income	$5.242M	-$1.069M	-$4.651M
YoY Change	1726.48%	-80.23%	94.77%
Depreciation, Depletion And Amortization	$300.0K	$320.0K	$380.0K
YoY Change	-28.57%	-21.95%	2.7%
Cash From Operating Activities	$2.610M	$2.020M	-$5.450M
YoY Change	210.71%	-138.55%	-3.71%
INVESTING ACTIVITIES
Capital Expenditures	-$580.0K	-$1.120M	-$800.0K
YoY Change	-19.44%	115.38%	300.0%
Acquisitions
YoY Change
Other Investing Activities	-$19.87M	-$44.48M
YoY Change
Cash From Investing Activities	-$20.45M	-$45.60M	-$800.0K
YoY Change	2740.28%	8669.23%	300.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-17.17M	1.910M	71.43M
YoY Change	-252.22%	-73.44%	142760.0%
NET CHANGE
Cash From Operating Activities	2.610M	2.020M	-5.450M
Cash From Investing Activities	-20.45M	-45.60M	-800.0K
Cash From Financing Activities	-17.17M	1.910M	71.43M
Net Change In Cash	-35.01M	-41.67M	65.18M
YoY Change	-407.11%	-3013.99%	-1221.86%
FREE CASH FLOW
Cash From Operating Activities	$2.610M	$2.020M	-$5.450M
Capital Expenditures	-$580.0K	-$1.120M	-$800.0K
Free Cash Flow	$3.190M	$3.140M	-$4.650M
YoY Change	104.49%	-166.53%	-14.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019	dei	Entity Registrant Name EntityRegistrantName	VERICEL CORPORATION
CY2019	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MI
CY2019	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3096597
CY2019	dei	Entity Address Address Line1 EntityAddressAddressLine1	64 Sidney Street
CY2019	dei	Entity Address City Or Town EntityAddressCityOrTown	Cambridge
CY2019	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2019	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02139
CY2019	dei	City Area Code CityAreaCode	800
CY2019	dei	Local Phone Number LocalPhoneNumber	556-0311
CY2019	dei	Security12b Title Security12bTitle	Common Stock (No par value)
CY2019	dei	Trading Symbol TradingSymbol	VCEL
CY2019	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019	dei	Entity Small Business EntitySmallBusiness	false
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019Q2	dei	Entity Public Float EntityPublicFloat	827617275	USD
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44945133	shares
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	489749000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	471180000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	21000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-39000	USD
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2018Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	104000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-378679000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-369014000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	111091000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	102231000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	153238000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118689000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117850000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90857000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	62760000	USD
CY2019	vcel	Other Revenue OtherRevenue	0	USD
CY2018	vcel	Other Revenue OtherRevenue	0	USD
CY2017	vcel	Other Revenue OtherRevenue	1164000	USD
CY2019	us-gaap	Revenues Revenues	117850000	USD
CY2018	us-gaap	Revenues Revenues	90857000	USD
CY2017	us-gaap	Revenues Revenues	63924000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	37571000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	32160000	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	30354000	USD
CY2019	us-gaap	Gross Profit GrossProfit	80279000	USD
CY2018	us-gaap	Gross Profit GrossProfit	58697000	USD
CY2017	us-gaap	Gross Profit GrossProfit	33570000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30391000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13599000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12944000	USD
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0000887359
CY2017	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	311000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	4700	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	514000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	306000	USD
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43578000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44864000	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43578000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44864000	shares
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Document Annual Report DocumentAnnualReport	true
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Transition Report DocumentTransitionReport	false
CY2019	dei	Entity File Number EntityFileNumber	001-35280
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	61139000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49007000	USD
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26889000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18286000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	42829000	USD
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	64638000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32168000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23454000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	6816000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	3558000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2953000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2847000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	111655000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	112783000	USD
CY2019Q4	vcel	Property Plantand Equipmentand Finance Lease Rightof Use Assetafter Accumulated Depreciationand Amortization PropertyPlantandEquipmentandFinanceLeaseRightofUseAssetafterAccumulatedDepreciationandAmortization	7144000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5906000	USD
CY2019Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	89000	USD
CY2018Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25103000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	9247000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD
CY2019Q4	us-gaap	Assets Assets	153238000	USD
CY2018Q4	us-gaap	Assets Assets	118689000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6345000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7108000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7948000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6930000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5461000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	41000	USD
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	754000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19795000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14792000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22242000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	110000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1666000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	42147000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	16458000	USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8176000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35610000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	91530000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	62606000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	48554000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-11251000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-3909000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-14984000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2524000	USD
CY2017	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	257000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-838000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-860000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	1614000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	897000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	14000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1732000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1107000	USD
CY2019	us-gaap	Interest Expense InterestExpense	20000	USD
CY2018	us-gaap	Interest Expense InterestExpense	31000	USD
CY2017	us-gaap	Interest Expense InterestExpense	92000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1586000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4228000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2302000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-9665000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-8137000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-17286000	USD
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.52
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	44180000	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40242000	shares
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33355000	shares
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-9665000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-8137000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-17286000	USD
CY2019	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	60000	USD
CY2018	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-39000	USD
CY2017	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9605000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17286000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	24708000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-17286000	USD
CY2017	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2680000	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7188000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	608000	USD
CY2017	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	425000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	207000	USD
CY2017	vcel	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	4010000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	22540000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-8137000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7223000	USD
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	70028000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3705000	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	656000	USD
CY2018	vcel	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	6255000	USD
CY2018	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-39000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	102231000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-9665000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13179000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4354000	USD
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	932000	USD
CY2019	vcel	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	0	USD
CY2019	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	60000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	111091000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-9665000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-8137000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-17286000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1744000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1426000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1612000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	13179000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	7223000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	2680000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2524000	USD
CY2017	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	257000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-838000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-860000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-42000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-51000	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-37000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-22000	USD
CY2017	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	115000	USD
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	610000	USD
CY2018	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	327000	USD
CY2017	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2019	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2787000	USD
CY2018	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
CY2017	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3258000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-235000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	305000	USD
CY2019	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	8714000	USD
CY2018	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	5184000	USD
CY2017	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1177000	USD
CY2019	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	106000	USD
CY2018	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1267000	USD
CY2017	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	261000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1024000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	899000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1361000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1018000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1493000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1050000	USD
CY2019	vcel	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-2512000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-64000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-208000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	826000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7183000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-412000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13183000	USD
CY2019	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	63092000	USD
CY2018	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	66549000	USD
CY2017	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	85577000	USD
CY2018	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	2200000	USD
CY2017	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	USD
CY2019	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	9254000	USD
CY2018	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
CY2017	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2616000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2678000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1510000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	10615000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-67027000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1510000	USD
CY2019	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	70028000	USD
CY2017	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5286000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4361000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8220000	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2018	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2017	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	30000	USD
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2018	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2716000	USD
CY2017	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4010000	USD
CY2019	us-gaap	Proceeds From Secured Lines Of Credit ProceedsFromSecuredLinesOfCredit	0	USD
CY2018	us-gaap	Proceeds From Secured Lines Of Credit ProceedsFromSecuredLinesOfCredit	0	USD
CY2017	us-gaap	Proceeds From Secured Lines Of Credit ProceedsFromSecuredLinesOfCredit	14793000	USD
CY2019	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2017	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	207000	USD
CY2019	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2018	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2017	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	889000	USD
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2018	us-gaap	Repayments Of Debt RepaymentsOfDebt	17532000	USD
CY2017	us-gaap	Repayments Of Debt RepaymentsOfDebt	7151000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	710000	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	583000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-26000	USD
CY2018	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2017	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5260000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	58863000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18577000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8692000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8576000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3884000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18286000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26862000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22978000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26978000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18286000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26862000	USD
CY2019	us-gaap	Nature Of Operations NatureOfOperations	<span style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization</span><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vericel Corporation, a Michigan corporation (together with its consolidated subsidiaries referred to herein as the Company, Vericel, we, us or our), was incorporated in March 1989 and began employee-based operations in 1991. On May 30, 2014, Vericel completed the acquisition of certain assets and assumed certain liabilities of Sanofi, a French </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">société anonyme</span><span style="font-family:inherit;font-size:10pt;"> (Sanofi), including all of the outstanding equity interests of Genzyme Biosurgery ApS (Genzyme Denmark or the Danish subsidiary) (now known as Vericel Denmark ApS), a wholly-owned subsidiary of Sanofi, and a portfolio of patents and patent applications of Sanofi and certain of its subsidiaries for purposes of acquiring the portion of the cell therapy and regenerative medicine business (the CTRM Business), related to the MACI</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;">, Carticel</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> and Epicel</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> products. The Company is a fully integrated, commercial-stage biopharmaceutical company and currently markets MACI</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> and Epicel</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> in the U.S. and holds exclusive rights to commercialize NexoBrid</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> in all countries of North America. The Company is a leader in advanced cell therapies for the sports medicine and severe burn care markets. </span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">MACI</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults that was approved by the FDA on December 13, 2016. The first shipment and implantation of MACI occurred on January 31, 2017. At the end of the second quarter of 2017, the Company removed Carticel</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> (autologous cultured chondrocytes), an earlier generation ACI product, from the market. The Company also markets Epicel</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> (cultured epidermal autografts), a permanent skin replacement Humanitarian Use Device (HUD) for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30 percent of total body surface area (TBSA). The Company operates its business primarily in the U.S. in </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> reportable segment — the research, product development, manufacture and distribution of cellular therapies for use in the treatment of specific diseases.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#222222;">The accompanying consolidated financial statements have been prepared on a basis which assumes that the Company will continue as a going concern and contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. As of </span><span style="font-family:inherit;font-size:10pt;color:#222222;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;color:#222222;">, the Company has an accumulated deficit of </span><span style="font-family:inherit;font-size:10pt;color:#222222;"><span>$378.7 million</span></span><span style="font-family:inherit;font-size:10pt;color:#222222;"> and had a net loss of </span><span style="font-family:Times_New_Roman;font-size:10pt;color:#222222;"><span>$9.7 million</span></span><span style="font-family:inherit;font-size:10pt;color:#222222;"> during 2019. The Company had cash and cash equivalents of </span><span style="font-family:inherit;font-size:10pt;color:#222222;"><span>$26.9 million</span></span><span style="font-family:inherit;font-size:10pt;color:#222222;"> and investments of </span><span style="font-family:inherit;font-size:10pt;color:#222222;"><span>$52.1 million</span></span><span style="font-family:inherit;font-size:10pt;color:#222222;"> as of </span><span style="font-family:inherit;font-size:10pt;color:#222222;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;color:#222222;">. The Company expects that existing cash, cash equivalents and investments will be sufficient to support the </span><span style="font-family:inherit;font-size:10pt;">Company’s</span><span style="font-family:inherit;font-size:10pt;color:#222222;"> </span><span style="font-family:inherit;font-size:10pt;">current operations through at least 12 months from the issuance of these financial statements.</span><span style="font-family:inherit;font-size:10pt;color:#222222;"> If revenues decline for a sustained period, we may need to access additional capital; however, the Company may not be able to obtain financing on acceptable terms or at all. The terms of any financing may adversely affect the holdings or the rights of the </span><span style="font-family:inherit;font-size:10pt;">Company’s</span><span style="font-family:inherit;font-size:10pt;color:#222222;"> shareholders.</span></div>
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-378700000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-9700000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26900000	USD
CY2019Q4	us-gaap	Investments Investments	52100000	USD
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reported period. Actual results could differ from those estimates.</span></div>
CY2019	vcel	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	104000	USD
CY2018	vcel	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	3538000	USD
CY2017	vcel	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	0	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	2599000	USD
CY2018	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2017	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	217000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	606000	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	341000	USD
CY2019	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2018	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2017	us-gaap	Stock Issued1 StockIssued1	38389000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	2230000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	931000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	100000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27000000.0	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26900000	USD
CY2019Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	100000	USD
CY2019Q1	vcel	Right Of Use Asset RightOfUseAsset	25600000	USD
CY2019Q1	vcel	Lease Liability LeaseLiability	27800000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	3900000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	2000000.0	USD
CY2019	vcel	Revenue Revenue Recognized Changein Uncollectible Analysis Percentage RevenueRevenueRecognizedChangeinUncollectibleAnalysisPercentage	0.005
CY2019	vcel	Revenue Revenue Recognized Effect Of0.5 Change In The Estimated Uncollectible Percentage Amount RevenueRevenueRecognizedEffectOf0.5ChangeInTheEstimatedUncollectiblePercentageAmount	500000	USD
CY2019	us-gaap	Revenues Revenues	117850000	USD
CY2018	us-gaap	Revenues Revenues	90857000	USD
CY2017	us-gaap	Revenues Revenues	63924000	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6085000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2872000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	541000	USD
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	638000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	190000	USD
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	48000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	6816000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	3558000	USD
CY2019Q4	vcel	Finance Lease Rightof Use Assetbefore Accumulated Amortization FinanceLeaseRightofUseAssetbeforeAccumulatedAmortization	148000	USD
CY2019Q4	vcel	Property Plantand Equipmentand Finance Lease Rightof Use Assetbefore Accumulated Depreciationand Amortization PropertyPlantandEquipmentandFinanceLeaseRightofUseAssetbeforeAccumulatedDepreciationandAmortization	16364000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13411000	USD
CY2019Q4	vcel	Property Plantand Equipmentand Finance Lease Rightof Use Asset Accumulated Depreciationand Amortization PropertyPlantandEquipmentandFinanceLeaseRightofUseAssetAccumulatedDepreciationandAmortization	9220000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7505000	USD
CY2019Q4	vcel	Property Plantand Equipmentand Finance Lease Rightof Use Assetafter Accumulated Depreciationand Amortization PropertyPlantandEquipmentandFinanceLeaseRightofUseAssetafterAccumulatedDepreciationandAmortization	7144000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5906000	USD
CY2019	us-gaap	Depreciation Depreciation	1700000	USD
CY2018	us-gaap	Depreciation Depreciation	1400000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	41000	USD
CY2019Q4	vcel	Lease Liability Payments Due Year Two LeaseLiabilityPaymentsDueYearTwo	5399000	USD
CY2017	us-gaap	Depreciation Depreciation	1600000	USD
CY2019Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	5116000	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	5161000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1785000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1559000	USD
CY2019Q4	vcel	Accrued Expenses Other Current AccruedExpensesOtherCurrent	1047000	USD
CY2018Q4	vcel	Accrued Expenses Other Current AccruedExpensesOtherCurrent	210000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7948000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6930000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	100000	USD
CY2019Q1	vcel	Right Of Use Asset RightOfUseAsset	25600000	USD
CY2019Q1	vcel	Lease Liability LeaseLiability	27800000	USD
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	5400000	USD
CY2019	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	100000	USD
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5200000	USD
CY2018	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	100000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25103000	USD
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	148000	USD
CY2019Q4	vcel	Right Of Use Asset RightOfUseAsset	25251000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5461000	USD
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	41000	USD
CY2019Q4	vcel	Lease Liability Current LeaseLiabilityCurrent	5502000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22242000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	110000	USD
CY2019Q4	vcel	Lease Liability Noncurrent LeaseLiabilityNoncurrent	22352000	USD
CY2019	vcel	Measurement Of Lease Liability MeasurementOfLeaseLiability	5000000.0	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	5461000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	41000	USD
CY2019Q4	vcel	Lease Liability Payments Due Next Twelve Months LeaseLiabilityPaymentsDueNextTwelveMonths	5502000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5358000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	205000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	41000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	41000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	41000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	41000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	41000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2019Q4	vcel	Operatingand Capital Leases Future Minimum Payments Due OperatingandCapitalLeasesFutureMinimumPaymentsDue	15591000	USD
CY2019Q4	vcel	Operatingand Capital Leases Future Minimum Payments Due Current OperatingandCapitalLeasesFutureMinimumPaymentsDueCurrent	4920000	USD
CY2019Q4	vcel	Operatingand Capital Leases Future Minimum Payments Due In Two Years OperatingandCapitalLeasesFutureMinimumPaymentsDueInTwoYears	4760000	USD
CY2019Q4	vcel	Operatingand Capital Leases Future Minimum Payments Due In Three Years OperatingandCapitalLeasesFutureMinimumPaymentsDueInThreeYears	4795000	USD
CY2019Q4	vcel	Operatingand Capital Leases Future Minimum Payments Due In Four Years OperatingandCapitalLeasesFutureMinimumPaymentsDueInFourYears	1007000	USD
CY2019Q4	vcel	Operatingand Capital Leases Future Minimum Payments Duein Five Years OperatingandCapitalLeasesFutureMinimumPaymentsDueinFiveYears	109000	USD
CY2019Q4	vcel	Operatingand Capital Leases Future Minimum Payments Due Thereafter OperatingandCapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5500000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5600000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	57436000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	21000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	57457000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	57457000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	75515000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	39000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	75476000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	75476000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	116000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4056000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1688000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-5445000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4790683	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.85
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M12D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11407000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2033760	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	17.51
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1197016	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.64
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	36561	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	26.16
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	537916	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	11.26
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5052950	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.35
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M12D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	37974000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2385824	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.49
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y6M
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	25113000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4700318	shares
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	16600000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	12400000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10300000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	700000	USD
CY2019Q4	vcel	Deferred Tax Assets Research And Development Costs DeferredTaxAssetsResearchAndDevelopmentCosts	7851000	USD
CY2018Q4	vcel	Deferred Tax Assets Research And Development Costs DeferredTaxAssetsResearchAndDevelopmentCosts	9067000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	418000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	4350000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2019Q4	vcel	Deferred Tax Asset Operating Lease Liability DeferredTaxAssetOperatingLeaseLiability	102000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-9665000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-8137000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-17286000	USD
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	44180000	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40242000	shares
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33355000	shares
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.52
CY2018Q4	vcel	Deferred Tax Asset Operating Lease Liability DeferredTaxAssetOperatingLeaseLiability	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	3303000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9665000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8137000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17286000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9665000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8137000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17286000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2030000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1709000	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5877000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-484000	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-385000	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1106000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1329000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-605000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	563000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-164000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	839000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	11749000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-49000	USD
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	172000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	2339000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	119000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10542000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10969000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	4329000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2798000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5316000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	41000	USD
CY2019Q4	vcel	Lease Liability Payments Due Year Three LeaseLiabilityPaymentsDueYearThree	5357000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5294000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	41000	USD
CY2019Q4	vcel	Lease Liability Payments Due Year Four LeaseLiabilityPaymentsDueYearFour	5335000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5302000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	USD
CY2019Q4	vcel	Lease Liability Payments Due Year Five LeaseLiabilityPaymentsDueYearFive	5302000	USD
CY2019Q4	vcel	Lessee Operating Lease Liability Payments Dueafter Year Six LesseeOperatingLeaseLiabilityPaymentsDueafterYearSix	11270000	USD
CY2019Q4	vcel	Finance Lease Liability Payments Dueafter Year Six FinanceLeaseLiabilityPaymentsDueafterYearSix	0	USD
CY2019Q4	vcel	Lease Liability Payments Due After Year Six LeaseLiabilityPaymentsDueAfterYearSix	11270000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	38001000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	164000	USD
CY2019Q4	vcel	Lease Liability Payments Due LeaseLiabilityPaymentsDue	38165000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10298000	USD
CY2019Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	13000	USD
CY2019Q4	vcel	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	10311000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	27703000	USD
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	151000	USD
CY2019Q4	vcel	Lease Liability LeaseLiability	27854000	USD
CY2019Q4	vcel	Lessee Lease Notyet Commenced Liability LesseeLeaseNotyetCommencedLiability	2100000	USD
CY2019	vcel	Lessee Lease Notyet Commenced Termof Contract LesseeLeaseNotyetCommencedTermofContract	P4Y3M18D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y9M18D
CY2019Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0944
CY2019Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0500
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	15386000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	4879000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4719000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4754000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	966000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	68000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	345000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	30596000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	25936000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	29991000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25936000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	605000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	605000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	605000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2014Q3	vcel	Operating Loss Carryforwards Limitations On Use Projected Annual Limitation On Use Of Net Operating Losses OperatingLossCarryforwardsLimitationsOnUseProjectedAnnualLimitationOnUseOfNetOperatingLosses	800000	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4100000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1700000	USD
CY2017Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpense	11700000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	700000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	USD
CY2015Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	600000	USD
CY2015Q4	vcel	Purchase Obligation Renewal Option Term PurchaseObligationRenewalOptionTerm	P5Y
CY2015Q4	vcel	Purchase Obligation Automatic Renewal Term PurchaseObligationAutomaticRenewalTerm	P5Y
CY2019Q4	us-gaap	Purchase Obligation PurchaseObligation	1821000	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	607000	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	607000	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	607000	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	0	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	0	USD
CY2019Q4	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	0	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21810000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26151000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30499000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39390000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117850000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	13170000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	17129000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	21175000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	28805000	USD
CY2019	us-gaap	Gross Profit GrossProfit	80279000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3358000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-20200000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3097000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	9210000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-11251000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2844000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-19792000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	3470000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	9501000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-9665000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18027000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19011000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22484000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31335000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90857000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	10361000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	11284000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	14346000	USD
CY2018Q4	us-gaap	Gross Profit GrossProfit	22706000	USD
CY2018	us-gaap	Gross Profit GrossProfit	58697000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4322000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4246000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1336000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	5995000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-3909000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-7659000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-4651000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-1069000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	5242000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-8137000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20

Files In Submission

Name	View Source	Status
0001628280-20-002229-index-headers.html	Edgar Link	pending
0001628280-20-002229-index.html	Edgar Link	pending
0001628280-20-002229.txt	Edgar Link	pending
0001628280-20-002229-xbrl.zip	Edgar Link	pending
a2019stockchartfinal.jpg	Edgar Link	pending
ex211subsidiariesofreg.htm	Edgar Link	pending
ex231consentofregister.htm	Edgar Link	pending
ex311certificationq420.htm	Edgar Link	pending
ex312certificationq420.htm	Edgar Link	pending
ex321certificationq420.htm	Edgar Link	pending
ex45descriptionofcapit.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vcel-20191231.xsd	Edgar Link	pending
vcel-20191231_cal.xml	Edgar Link	unprocessable
vcel-20191231_def.xml	Edgar Link	unprocessable
vcel-20191231_lab.xml	Edgar Link	unprocessable
vcel-20191231_pre.xml	Edgar Link	unprocessable
vcel12-31x201910k.htm	Edgar Link	pending
vcel12-31x201910k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VCEL
Vericel Corp Stock $vcel

2018 Q4 Form 10-K Financial Statement

#000162828020002229 Filed on February 25, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCEL Vericel Corp Stock $vcel

2018 Q4 Form 10-K Financial Statement

#000162828020002229 Filed on February 25, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCEL
Vericel Corp Stock $vcel